These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19901690)
1. Concerns regarding the methodology of the study entitled "Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?". Suzuki H; Kagawa H; Iwata K J Trauma; 2009 Nov; 67(5):1133; author reply 1133-4. PubMed ID: 19901690 [No Abstract] [Full Text] [Related]
2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? Eachempati SR; Hydo LJ; Shou J; Barie PS J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237 [TBL] [Abstract][Full Text] [Related]
3. Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia? Pea F; Viale P J Trauma; 2009 Oct; 67(4):893-4; author reply 894-5. PubMed ID: 19820604 [No Abstract] [Full Text] [Related]
4. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic therapy for ventilator-associated pneumonia: de-escalation in the real world. Depuydt P; Blot S Crit Care Med; 2007 Feb; 35(2):632-3. PubMed ID: 17251705 [No Abstract] [Full Text] [Related]
9. A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia. Khan RA; Aziz Z Int J Clin Pharm; 2017 Aug; 39(4):906-912. PubMed ID: 28643112 [TBL] [Abstract][Full Text] [Related]
11. De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia? Niederman MS; Soulountsi V Clin Chest Med; 2011 Sep; 32(3):517-34. PubMed ID: 21867820 [TBL] [Abstract][Full Text] [Related]
12. Tigecycline use in critically ill older patients: case reports and critical analysis. Curcio D; Fernández F; Duret F J Am Geriatr Soc; 2007 Feb; 55(2):312-3. PubMed ID: 17302676 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia. Benko R; Matuz M; Doro P; Peto Z; Molnar A; Hajdu E; Nagy E; Gardi J; Soos G Int J Antimicrob Agents; 2007 Aug; 30(2):162-8. PubMed ID: 17570646 [TBL] [Abstract][Full Text] [Related]
14. Which is the right antibiotic treatment for ventilator-associated pneumonia? Corona A Crit Care Med; 2007 Jul; 35(7):1808; author reply 1808-9. PubMed ID: 17581392 [No Abstract] [Full Text] [Related]
15. How can earlier antibiotic efficacy be provided for ventilator-associated pneumonia without promoting bacterial resistance? Is initial monotherapy or a combination of antibiotics the right answer? Papazian L Crit Care Med; 2008 Mar; 36(3):994-5. PubMed ID: 18431296 [No Abstract] [Full Text] [Related]
16. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Morris AC; Kefala K; Simpson AJ; Wilkinson TS; Everingham K; Kerslake D; Raby S; Laurenson IF; Swann DG; Walsh TS Thorax; 2009 Jun; 64(6):516-22. PubMed ID: 19213771 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic selection is crucial for optimal empiric monotherapy of ventilator-associated pneumonia. Cunha BA Crit Care Med; 2007 Aug; 35(8):1992-4. PubMed ID: 17667252 [No Abstract] [Full Text] [Related]